pipette
ESEspañol

Engineering the paclitaxel biosynthetic pathway in Physcomitrium patens for de novo and stable biosynthesis

Mengkai Zhao, Wenchang Lu, Renhai Peng, Liyan Wang, Ali Raza, Bin Jia, Zhangli Hu

Peer-reviewed journalClaims a big stepReal-world use

In the authors' words

Abstract Paclitaxel is a highly valuable diterpenoid anticancer drug originally extracted from the yew tree. Due to the low efficiency of plant extraction and the high cost of semi-synthesis, efforts have been made to produce paclitaxel through biosynthesis. However, there have been no reports to date on engineered strains capable of paclitaxel biosynthesis. Here, we engineer a paclitaxel-producing line using the moss ( Physcomitrium patens ) chassis cells by combining transient expression verification, cytoplasmic localization strategies, self-cleaving 2 A peptide-mediated multi-gene co-expression systems and a modular iterative transformation strategy for stable genetic inheritance. Even after continuous subculturing multiple times, the engineered paclitaxel-producing lines obtained through both the initial reconstructed pathway and the optimized pathway are able to stably produce paclitaxel. This study proposes that Physcomitrium patens can serve as a plant chassis for paclitaxel biosynthesis.

Main resultThe abstract does not state a limitation.

In plain words AI summary

Paclitaxel is a valuable cancer drug originally extracted from yew trees. Plant extraction is inefficient and semi-synthesis is expensive. No engineered strains could produce paclitaxel until now. The authors engineered moss cells to produce paclitaxel using multiple genetic techniques. The engineered moss lines stably produce paclitaxel even after repeated subculturing. This moss can serve as a plant chassis for paclitaxel production.

Written by Kimi K2.5 using only the abstract above. Jev checked that every sentence is supported by the abstract sentences it cites, and removed any that were not. Point at a sentence to highlight its source.

Appeared: Friday, October 23. Nature Communications. Peer-reviewed journal.

DOI: 10.1038/s41467-026-76625-x